Add some hearings..
1983
Oversight on implementation of the Orphan Drug Act (Public Law 97-414) : hearing before the Committee on Labor and Human Resources, United States Senate, Ninety-eighth Congress, first session, on reviewing the radioepidemiological tables and thyroid cancer research (section 7 of the Orphan Drug Act, Public Law 97-414), April 12, 1983. http://catalog.hathitrust.org/Record/011342996
….
1985
FDA issues : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, risks and benefits of raw milk, February 13, 1985; Emergency Reye’s Syndrone Prevention Act of 1985, March 15, 1985; Orphan Drug Act reauthorization, March 20, 1985. http://catalog.hathitrust.org/Record/003491125
An Act to Amend the Orphan Drug Provisions of the Federal Food, Drug, and Cosmetic Act and Related Laws. http://catalog.hathitrust.org/Record/102223410
1987
Drug issues : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, October 1, 1987 https://catalog.gpo.gov/F/522D9HHIDGC2MYA9YE1XBAGL3XBF2C44RUDEJDGQEMFULIYBEL-00121?func=full-set-set&set_number=001974&set_entry=000014&format=999
1990
Orphan Drug Act : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 7, 1990. https://catalog.gpo.gov/F/522D9HHIDGC2MYA9YE1XBAGL3XBF2C44RUDEJDGQEMFULIYBEL-00115?func=full-set-set&set_number=001974&set_entry=000011&format=999
1991
1992
Anticompetitive Abuse of the Orphan Drug Act : invitation to high prices : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, second session, on S. 2060, a bill to revise the orphan drug provisions of the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act, and for other purposes, January 21, 1992. http://catalog.hathitrust.org/Record/008517675
Orphan Drug Amendments of 1991 : hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, second session, on S. 2060, Tuesday, March 3, 1992. 4.L 11/4:S.HRG.102-860
1993
1994
Orphan drug reauthorization : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994. https://catalog.hathitrust.org/Record/003485048
1995
1996
1997
Legislative proposal to increase funding for medical research : Hearing before the Subcommittee of the Committee on Appropriations, United States Senate, One Hundred Fifth Congress, First Session. October 21, 1997. https://www.govinfo.gov/content/pkg/CHRG-105shrg46160/html/CHRG-105shrg46160.htm
2000
Securing the health of the American people : Hearing before the Subcommittee on Health and Environment, One Hundred Sixth Congress, second session. September 13, 2000. https://www.govinfo.gov/content/pkg/CHRG-106hhrg67114/html/CHRG-106hhrg67114.htm
2008
Small market drugs, big price tags: Are drug companies exploiting people with rare disease? : Hearing before the Joint Economic Committee, One Hundred Tenth Congress, second session. July 24, 2008. https://www.govinfo.gov/content/pkg/CHRG-110shrg44974/html/CHRG-110shrg44974.htm